Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking.
about
Psychological interventions for co-occurring depression and substance misusePharmacological treatment for depression during opioid agonist treatment for opioid dependenceImpaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphineThe efficacy of behavioural activation treatment for co-occurring depression and substance use disorder (the activate study): a randomized controlled trialPrevalence of psychiatric disorders among young injection drug users.Somatic health among heroin addicts before and during opioid maintenance treatment: a retrospective cohort studyToward the Identification of a Specific Psychopathology of Substance Use Disorders.Psychopathological symptoms of patients with heroin addiction entering opioid agonist or therapeutic community treatment.Psychiatric correlates of injection risk behavior among young people who inject drugs.The association between naltrexone treatment and symptoms of depression in opioid-dependent patientsImproving the retention rate for residential treatment of substance abuse by sequential intervention for social anxietyComparative profiles of men and women with opioid dependence: results from a national multisite effectiveness trial.Hepatitis C virus infection is independently associated with depression among methadone maintenance treatment heroin users in ChinaDepressive symptoms, substance use, and HIV-related high-risk behaviors among opioid-dependent individuals: results from the Clinical Trials Network.Profiles of psychiatric disorders among heroin dependent individuals in Changsha, China.Comparison of socio-demographic characteristics, substance, and depression among male heroin users attending therapeutic community and methadone maintenance treatment program in Nantou, Taiwan.The mental status of 1090 heroin addicts at entry into treatment: should depression be considered a 'dual diagnosis'?The Effects of Family-Centered Problem-Solving Education on Relapse Rate, Self Efficacy and Self Esteem Among Substance AbusersMeta-analysis of depression and substance use and impairment among intravenous drug users (IDUs)The role of depression and social support in non-fatal drug overdose among a cohort of injection drug users in a Canadian setting.Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? A patient safety issue.Clinical characteristics of treatment-seeking adolescents with opioid versus cannabis/alcohol use disordersSix-month follow-up of Iranian women in methadone treatment: drug use, social functioning, crime, and HIV and HCV seroincidence.Pathways to heroin dependence: time to re-appraise self-medication.Effect of comorbid depression on substance use disorders.Mental health symptoms among street-based psychostimulant injectors in Sydney's Kings Cross.'Crisis' and 'everyday' initiators: A qualitative study of coercion and agency in the context of methadone maintenance treatment initiation.Use of a multi-state model in a claims database: illustration with methadone.Moving toward personalized medicine in the methadone maintenance treatment program: a pilot study on the evaluation of treatment responses in Taiwan.Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration.An audit examining the impact of a training session on interest in prescribing opioid maintenance treatment among psychiatrists and trainees.Perceived need for depression treatment among persons entering inpatient opioid detoxification.Mental health of heroin users with differing injection drug use histories: A non-treatment sample of Mexican American young adult men.Gender and Age Effects on the Trajectory of Depression in Opioid Users during Methadone Maintenance Treatment.Double whammy: Adverse childhood events and pain reflect symptomology and quality of life in women in substance abuse treatment.Can heroin-dependent individuals benefit from a methadone maintenance treatment program before they drop out against medical advice? A 12-month follow-up study.The utility of the Mood Disorders Questionnaire as a screening tool in a methadone maintenance treatment program.Heroin refusal self-efficacy and preference for medication-assisted treatment after inpatient detoxification.Changes in Australian injecting drug users’ mental health problems and service uptake from 2006-2012Complex vulnerabilities as barriers to treatment for illicit drug users with high prevalence mental health co-morbidities
P2860
Q24234728-E17F382B-BE1A-4D13-A975-6213A8EC7750Q24235458-30E0E93F-2EF2-47A4-9A7C-BBEC8D08D0C5Q24605833-B3594090-1D1B-40C3-B5FD-E92A42DA7AF0Q27310906-0EB8691F-D5AA-4BF7-A705-E8140B3C0D60Q30514051-FB347918-30A9-4850-9065-1A615ABB07E3Q33317649-F975A9A5-9296-4219-A4AF-9338AD8EECE3Q33607241-3B5D4002-9053-433B-A928-CC8C1F98187AQ34586382-6EA744DF-0820-4217-937A-E69BC39178FEQ34758775-C1754230-6DF5-4B21-84AB-9D88BBA87CEEQ35034221-05671E5C-E111-468F-947C-AB57CBAC8B01Q35095767-34F56FC7-7DCF-4D61-AD90-672EA5BC1683Q35189633-F2FA77F4-DFC1-4F60-A19D-5BDCDA369604Q35885462-110947D9-C9E3-4F4F-964D-C3AE76B5BDA0Q36089195-F0469090-CF76-4AEF-91EC-03D136A5EB97Q36173346-F375843B-9781-4D61-A297-19FFBDDBD3F1Q36220534-EB174EDD-1071-449E-AC6E-0BBB6642525BQ36409749-21FE2C9E-43B3-4472-BFFB-D75F149F76D2Q36879657-2EA2D663-2B77-4FC2-B9AF-29558EFD552FQ36894307-5C03E739-283B-4855-85AF-CF3F28BB88F5Q37164972-E62E8EF9-46B4-4BD6-AC95-63AEC10EA927Q37305173-248175D0-8036-4880-BF7C-CA2DCD0D97C8Q37379413-97BD3D9F-DDC5-4395-A100-0C5C04CF0B86Q37467821-B11FB045-A870-4C32-B080-73CF2F8B00CEQ38052920-CD3869D5-0340-4E8A-A6E5-33BCA8E719F7Q38994541-264FEC80-4A4F-484F-9E7D-2AE625E38430Q39931556-98851129-63C6-41ED-B2FE-9E4620197448Q40694556-20CFCBE3-CFFB-4AB5-A9DC-6027974D39E9Q40736159-4F9334EE-1308-40CC-8DE1-775B37AAA9F5Q41987974-03A6E8BA-29CB-4AAB-97AC-4D3A4BF32307Q44330216-3DBADFC7-18E9-4F4B-BE79-4F0CE9A757FCQ44343343-C9570CB4-C685-440F-83AA-EFE1CF33DDD9Q44345240-C42F29BE-AF08-4CDD-AFC4-C82FB26A5076Q46166414-9FE0B14E-9EFA-40D5-94C2-7A1DE35002D6Q47555426-D4309125-33FC-4C7C-AC74-32D5539B4FF8Q47588067-F85F6CDD-F0B4-43EA-8638-76CAD84D5BADQ48348298-7E36CA3F-8AA1-441D-A52E-79456A9A8627Q51850467-B527E670-A47A-4A46-9794-911511C7CF41Q53911633-1B6E2722-83FF-429A-BB5C-673666CD9C0CQ57409602-ED704DCA-5121-491F-B2DD-94697FE8D888Q59238934-157CD0E9-38AE-437A-979B-958C211E188E
P2860
Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Depression among entrants to t ...... relates and treatment seeking.
@en
Depression among entrants to t ...... relates and treatment seeking.
@nl
type
label
Depression among entrants to t ...... relates and treatment seeking.
@en
Depression among entrants to t ...... relates and treatment seeking.
@nl
prefLabel
Depression among entrants to t ...... relates and treatment seeking.
@en
Depression among entrants to t ...... relates and treatment seeking.
@nl
P50
P1476
Depression among entrants to t ...... relates and treatment seeking.
@en
P2093
Sandra Fairbairn
P304
P356
10.1016/J.DRUGALCDEP.2004.12.001
P577
2005-06-01T00:00:00Z